Skip to content

Trial Summary

CL-SBP-101-03

Acronym:

CL-SBP-101-03

ACTRN/NCT /ethics:

NCT03412799

Scientific title:

Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer

Sponsor / Cooperative group:

Sun BioPharma Inc

Trial & Patient Characteristics

Cancer TypePancreas
Trial TypeTreatment
PhasePhase I
Age Range18 years and older
SexBoth
Tumour Stream -
Cancer StageMetastatic or Widespread
Anticipated Start Date2018-06-04
Anticipated End Date-

Participating Hospitals

HospitalAshford Cancer Centre Research
Clinical Trial CoordinatorSue Yeend
Emailsyeend@adelaidecancercentre.com.au
Phone08 8292 2240
Principal InvestigatorDr Nimit Singhal
Recruitment StatusRecruiting